Robert G Moussa insider trades: Derma Sciences (DSCI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 13, 2015 | DSCI | ↑ Buy | 5,000 | $6.61 | $33K | Direct | Aug 14, 2015 (1d) |
| Feb 10, 2011 | DSCI | ↓ Sell | 5,000 | $12.60 | $63K | Direct | Feb 11, 2011 (1d) |
| Sep 19, 2008 | DSCI | ↑ Buy | 20,000 | $10800.00 | $216.0M | Direct | Sep 22, 2008 (3d) |
| Dec 3, 2007 | DSCI | ↑ Buy | 20,000 | $0.65 | $13K | Direct | Dec 3, 2007 (0d) |
| Oct 31, 2006 | DXR | ↑ Buy | 500 | $15.29 | $8K | Direct | Oct 31, 2006 (0d) |
| Aug 30, 2006 | DSCI | ↑ Buy | 15,000 | $0.74 | $11K | Direct | Aug 31, 2006 (1d) |
| Jun 16, 2006 | DXR | ↑ Buy | 500 | $17.84 | $9K | Direct | Jun 20, 2006 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Robert G Moussa's insider trades
Robert G Moussa is a director at Derma Sciences (DSCI). Since Jun 16, 2006, Robert has reported 6 open-market purchases worth $216.1M and 1 sale worth $63K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), option exercises (3 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DSCI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.